Cargando…

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells

Chimeric antigen receptor modified T cells (CAR-T) therapy is an emerging immunotherapy against malignancies. However, only limited success was obtained in solid tumors. Polyinosinic-polycytidylic acid (poly I:C), ligand of TLR3, mediates innate immune and adaptive immune and shows broad antitumor e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di, Shengmeng, Zhou, Min, Pan, Zeyan, Sun, Ruixin, Chen, Muhua, Jiang, Hua, Shi, Bizhi, Luo, Hong, Li, Zonghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481273/ https://www.ncbi.nlm.nih.gov/pubmed/31058074 http://dx.doi.org/10.3389/fonc.2019.00241

Ejemplares similares

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
por: Luo, Hong, et al.
Publicado: (2019)

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer
por: Liu, Yifan, et al.
Publicado: (2023)

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
por: Jiang, Hua, et al.
Publicado: (2017)

An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment
por: Wang, Yi, et al.
Publicado: (2019)

Combined adjuvants of poly(I:C) plus LAG‐3‐Ig improve antitumor effects of tumor‐specific T cells, preventing their exhaustion
por: Kano, Yosuke, et al.
Publicado: (2016)

Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
por: Marques, Rodolfo F., et al.
Publicado: (2022)

A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
por: De Waele, Jorrit, et al.
Publicado: (2021)

Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant
por: Hernandez-Franco, Juan F., et al.
Publicado: (2022)

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
por: Anfray, Clément, et al.
Publicado: (2021)

A Nanoparticle-Poly(I:C) Combination Adjuvant Enhances the Breadth of the Immune Response to Inactivated Influenza Virus Vaccine in Pigs
por: Renu, Sankar, et al.
Publicado: (2020)

Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Ovalbumin-Specific Cell Mediated Immunity in Mice Model
por: Ahn, So Yeon, et al.
Publicado: (2021)

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs
por: Thomas, Milton, et al.
Publicado: (2015)

Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor‐conditioned macrophages
por: Maeda, Akihiro, et al.
Publicado: (2019)

Arginine-Based Poly(I:C)-Loaded Nanocomplexes for the Polarization of Macrophages Toward M1-Antitumoral Effectors
por: Dacoba, Tamara G., et al.
Publicado: (2020)

Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines
por: Le, Chau Thuy Tien, et al.
Publicado: (2023)

A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C
por: Aznar, M. Angela, et al.
Publicado: (2019)

In vitro effects of monophosphoryl lipid A and Poly I:C combination on equine cells
por: Lee, Dong-Ha, et al.
Publicado: (2023)

Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC)
por: Levitzki, Alexander
Publicado: (2012)

Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity
por: Kim, Eun-Do, et al.
Publicado: (2015)

Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
por: Sabbaghi, Ailar, et al.
Publicado: (2021)

Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation
por: Le, Chau Thuy Tien, et al.
Publicado: (2021)

Exploiting poly(I:C) to induce cancer cell apoptosis
por: Bianchi, Francesca, et al.
Publicado: (2017)

Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
por: Zhu, Ping, et al.
Publicado: (2023)

Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors
por: Sun, Yansha, et al.
Publicado: (2022)

SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques
por: Yamamoto, Tetsuro, et al.
Publicado: (2023)

Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
por: Li, You, et al.
Publicado: (2020)

Polysaccharide of Radix Pseudostellariae Improves Chronic Fatigue Syndrome Induced by Poly I:C in Mice
por: Sheng, Rong, et al.
Publicado: (2011)

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride
por: Kniazeva, Volha, et al.
Publicado: (2023)

Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
por: Muthuswamy, Ravikumar, et al.
Publicado: (2015)

Control of Interferon Production in Rabbit Cells Treated with Poly I:C
por: Armstrong, John A.
Publicado: (1970)

Pathological Role of Interleukin-17 in Poly I:C-Induced Hepatitis
por: He, Jianqin, et al.
Publicado: (2013)

Towards a Mechanism for Poly(I·C) Antiviral Priming in Oysters
por: Martins, Nelson E.
Publicado: (2020)

Poly I:C causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund's complete adjuvant
por: De Alba, Jorge, et al.
Publicado: (2013)

Synergistic antitumor efficacy against the EGFRvIII(+)HER2(+) breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12
por: Xu, Wen, et al.
Publicado: (2015)

Inhibition of Poly(I:C)-Induced Inflammation by Salvianolic Acid A in Skin Keratinocytes
por: Zhang, Qing-Ling, et al.
Publicado: (2019)

Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine Boosting
por: Chuai, Xia, et al.
Publicado: (2013)

Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C
por: Da Silva, Diane M., et al.
Publicado: (2015)

Sex differences and similarities in the neuroimmune response to central administration of poly I:C
por: Posillico, Caitlin K., et al.
Publicado: (2021)

Mouse primary microglia respond differently to LPS and poly(I:C) in vitro
por: He, Yingbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gr2usigdjbf1c3mdq7dh2s76hf